Tseleni-Balafouta S, Kavantzas N, Alevizaki M, Paraskevakou H, Davaris P
Dept. of Pathology, Medical School, University of Athens, Greece.
J Exp Clin Cancer Res. 1998 Dec;17(4):533-7.
The presence of NE-differentiation in the follicle-cell thyroid carcinoma has been investigated by immunohistochemical detection of chromogranin A in the neoplastic cells. It has been found that NE-differentiation was present in a significant percentage in the papillary Ca alone (46.60%) whereas all Huerthle-cell neoplasms and the large majority of follicular and undifferentiated carcinomas showed non reactivity for Chromogranin A. Moreover, we have correlated the presence of NE-differentiation to well known prognostic factors in papillary Ca. We found a statistically significant correlation between the neuroendocrine differentiation and some unfavourable factors such as old age of the patient, size of the tumor, invasion of thyroid capsule and lymphnode involvement. We suggested that NE-differentiation could be considered as an index of poor prognosis.
通过对肿瘤细胞中嗜铬粒蛋白A进行免疫组织化学检测,研究了滤泡细胞甲状腺癌中神经内分泌分化的存在情况。研究发现,仅乳头状癌中存在显著比例的神经内分泌分化(46.60%),而所有许特莱细胞肿瘤以及大多数滤泡癌和未分化癌对嗜铬粒蛋白A均无反应。此外,我们将神经内分泌分化的存在与乳头状癌中众所周知的预后因素进行了关联。我们发现神经内分泌分化与一些不利因素之间存在统计学上的显著相关性,如患者年龄较大、肿瘤大小、甲状腺包膜侵犯和淋巴结受累。我们认为神经内分泌分化可被视为预后不良的一个指标。